SCHEMBL4397410

SCHEMBL4397410

NN=C(N)c1ccc2c(c1)NC(=O)C2

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
AHR P35869 4/20 0.50
SMYD3 Q9H7B4 3/20 0.50
CMA1 P23946 2/20 0.50
CRBN Q96SW2 2/20 0.49
EIF2AK2 P19525 1/20 0.49
PDK2 Q15119 1/20 0.43
HDAC6 Q9UBN7 1/20 0.41
CREBBP Q92793 1/20 0.41
TDP2 O95551 3/20 0.41
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HSD11B1 P28845 2/20 0.39
MGLL Q99685 1/20 0.38
CA9 Q16790 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12652681 0.88 AHR (0.50) AHRSMYD3CMA1CRBNEIF2AK2
SCHEMBL4398575 0.88 AHR (0.50) AHRSMYD3CMA1CRBNEIF2AK2
SCHEMBL4394999 0.88 SMYD3 (0.50) AHRSMYD3PDK2HDAC3
Hydrochloric Acid SCHEMBL4399726 0.86 SMYD3 (0.49) AHRSMYD3HDAC3
SCHEMBL30760741 0.83 SMYD3 (0.58) AHRSMYD3CMA1CRBNEIF2AK2
SCHEMBL3194345 0.83 SMYD3 (0.58) AHRSMYD3CMA1CRBNEIF2AK2
Hydrochloric Acid SCHEMBL29528151 0.82 SMYD3 (0.57) AHRSMYD3CMA1CRBNEIF2AK2
SCHEMBL3573876 0.78 SMYD3 (0.56) AHRSMYD3CMA1CRBNEIF2AK2
SCHEMBL398818 0.77 TDP2 (0.66) AHRSMYD3CMA1CRBNEIF2AK2
SCHEMBL29713338 0.77 TDP2 (0.66) AHRSMYD3CMA1CRBNEIF2AK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101321525-B Heteroaryl substituted piperidine derivatives as L-CPT1 inhibitors HOFFMANN LA ROCHE 2013-01-30 CN disclosed
EP-1959951-B1 HETEROARYL SUBSTITUTED PIPERIDINE DERIVATIVES AS L-CPT1 INHIBITORS HOFFMANN LA ROCHE (CH) 2009-12-23 EP disclosed